Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States

Galarce, Ezequiel M.; Minsky, Sara; Viswanath, Kasisomayajula

doi:10.1016/j.vaccine.2011.05.014

Cited by 160 publications

(152 citation statements)

References 10 publications

Supporting

Mentioning

137

Contrasting

Order By: Relevance

“…1 Socioeconomic and racial/ethnic disparities exist in IV coverage rates. [5][6][7][8][9] IV uptake is lower in circumstances associated with poverty. Poverty accounts for numerous barriers that interfere with receipt of immunizations, including the financial burden of vaccine administration, lack of access to medical care, and lack of understanding of vaccine importance and safety.…”

Section: Introductionmentioning

confidence: 99%

“…Poverty accounts for numerous barriers that interfere with receipt of immunizations, including the financial burden of vaccine administration, lack of access to medical care, and lack of understanding of vaccine importance and safety. 5,9 African Americans and Hispanics are less likely than non-Hispanic Whites to have received IV, possibly due to cultural and ethnic differences in vaccine attitudes. 7 There are few studies, however, describing vaccine attitudes by age, gender, or race/ethnicity in low-income communities.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Influenza vaccine hesitancy in a low-income community in central New York State

Suryadevara

Bonville

Rosenbaum

et al. 2014

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Influenza vaccine hesitancy in a low-income community in central New York State

Suryadevara

Bonville

Rosenbaum

et al. 2014

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

“…15 There is growing literature that examines the importance of communication and trust specifically related to vaccination behavior during a pandemic. 12,[16][17][18] Freimuth et al 13 found a small association between trust and vaccination, but 2 studies found that communication about vaccines from official government sources was a consistent predictor of higher vaccination rates during the pandemic, resulting in a call for sufficient, clear, and timely communication to ''maintain public confidence and trust to increase compliance. '' 12(pD10) Additional research suggests that people who relied on unofficial sources were less likely to be vaccinated and that, during the H1N1 pandemic in the United States, mistrust and conspiracy theories promulgated by local clergy, the media, and social media sources were potential factors in H1N1 immunization disparities in African Americans.…”

mentioning

confidence: 99%

Exploring Communication, Trust in Government, and Vaccination Intention Later in the 2009 H1N1 Pandemic: Results of a National Survey

Quinn

Parmer²,

Freimuth³

et al. 2013

Biosecurity and Bioterrorism: Biodefense Strategy, Practice, an

205

184

View full text Add to dashboard Cite

With the growing recognition of the critical role that risk communication plays in a public health emergency, a number of articles have provided prescriptive best practices to enhance such communication. However, little empirical research has examined perceptions of the quality of communication, the impact of uncertainty on changing communication, use of information sources, and trust in specific government spokespersons. Similarly, although there is significant conceptual focus on trust and communication as important in vaccination intent and acceptance, little research has explored these relationships empirically. We conducted an online survey in late January 2010 with a nationally representative sample (N = 2,079) that included Hispanic and African American oversamples. The completion rate was 56%. We found that public health officials were the most trusted spokespersons, with President Obama being the most highly trusted elected official. Demographic variables, including race, accounted for 21% of the variance in trust of the president. Perceptions of the quality of communication were high, including significant understanding of uncertainty and appreciation for officials' openness about evolving information. Other factors that contributed to vaccination acceptance were quality of communication, closely following the news, and confidence in the vaccine because of a role model effect of the Obama daughters' immunizations; these factors significantly increased trust in government actions. Because the challenges of communication often vary over the course of a pandemic, there is a consistent need to pay close attention to both communication content and delivery and prepare public health officials at all levels to be effective communicators.

show abstract

“…These associations hold both for persons who are not health care professionals (see, e.g., Dekker 2006 ;Flood et al 2010 ;Galarce et al 2011 ;Raude et al 2010 ), and for decisions of health care professionals to get vaccinated (e.g., Maltezou et al 2010 ;Betsch et al 2011 ).…”

Section: Attitude Toward Vaccinationmentioning

confidence: 99%

“…Vaccination against one infection is often associated with vaccination against others (e.g., Galarce et al 2011 ;Vaux et al 2011 ;Bish et al 2011 ;Chor et al 2011 ). For example, vaccination against HPV was associated with vaccination against hepatitis B (Jain et al 2009 ), and receiving a recent infl uenza vaccination was associated with receiving an adult tetanus, diphtheria, and acellular pertussis booster (Tdap vaccination, Miller et al 2011 ).…”

Section: Other Factorsmentioning

confidence: 99%

Vaccine Marketing

Angelmar¹,

Morgon²

2013

International Series in Quantitative Marketing

View full text Add to dashboard Cite

Long perceived as an unattractive segment of the pharmaceutical industry, most of the leading fi rms have stepped up vaccine investments in recent years. Unlike mainstream pharmaceuticals, vaccines generally treat healthy individuals, most are administered only once or very infrequently during a life time, and they engender positive externalities, because vaccinated individuals reduce the risk of transmission to unvaccinated persons, leading authorities to mandate some vaccinations. Resistance to vaccination may lead to immunization failure and disease resurgence.The public and private market each account for about one-half of the global vaccine market in value. Bringing new vaccines to market requires carefully orchestrated programs targeting the multiple types of customers. For example, in parallel with the clinical development program designed to obtain FDA approval for its HPV vaccine Gardasil, Merck developed health-economic evidence to obtain a positive recommendation for vaccination and public fi nancing. Physician educational programs and unbranded DTC campaigns were started many months prior to launch. Following FDA approval and positive vaccination and public fi nancing recommendations, Merck developed market access programs targeted at states and private insurers, and launched branded physician and DTC campaigns.Successful global diffusion of a vaccine generally requires the development of a tiered pricing policy which takes country differences in per capita income into account.A successful launch often creates new problems for vaccine marketers. They must maintain the motivation to engage in and pay for vaccination despite the quasi-disappearance of the disease. And they must combat anti-vaccination information claiming that the vaccine is the cause of serious side effects.

show abstract

Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States

Cited by 160 publications

References 10 publications

Influenza vaccine hesitancy in a low-income community in central New York State

Influenza vaccine hesitancy in a low-income community in central New York State

Exploring Communication, Trust in Government, and Vaccination Intention Later in the 2009 H1N1 Pandemic: Results of a National Survey

Vaccine Marketing

Contact Info

Product

Resources

About